Rheumatic diseases
Conditions
Interventions
Rheumatic group:No
Sponsors
Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion Criteria (Disease group) 1. Age > 18 years old 2. The diagnosis of rheumatic diseases was in accordance with the criteria of the classification of rheumatic diseases. 3. The functions of major organs were basically normal without serious metabolic related diseases; He did not participate in other relevant drug clinical trials during the screening period. 4. No intellectual and mental disorders, normal language expression ability, and basic judgment ability of their own condition. Inclusion Criteria (Healthy group) 1. Age > 18 years old 2. The distribution of age and gender (treatment group and control group) was consistent 3. The main organ function was basically normal, and there was no serious metabolic related disease 4. No serious hypertension, diabetes, hyperlipidemia and other diseases and no treatment drugs 5. Did not participate in other relevant drug clinical trials during the s
Exclusion criteria
Exclusion criteria: Exclusion Criteria (Disease group) 1. Patients with severe acute infection, severe anemia, severe cardiovascular and cerebrovascular diseases, and severe liver and kidney insufficiency 2, pregnant, pregnant or lactating women, psychiatric patients 3, suffering from jaundice and severe metabolic system diseases, autoimmune deficiency diseases 4, patients in ongoing trials of other drugs 5, extreme failure, expected survival time less than 2 months Exclusion Criteria (Healthy group) 1. Those who had used any drugs affecting the immune system within 3 months before the trial 2, those vaccinated within 3 months before the trial 3. For other reasons, the subjects were unable to complete the study or had other reasons not suitable for participating in the study as judged by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Metabolism research; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in tumor markers associated with rheumatic diseases;Characteristics of rheumatic diseases combined with malignant tumor diseases; | — |
Countries
China
Contacts
Public ContactXi Yupng
Guang 'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed